Congenital Factor Xiii Deficiency
📧 Sign up to get email alerts when something new happens for Congenital Factor Xiii Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan
The trial reports safety and effectiveness data for NovoThirteen (recombinant Factor XIII, rFXIII) in treating congenital Factor XIII defici…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of recombinant Factor XIII in healthy volunteers. The results summarize tolerability and…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency [Phase 1]
Phase 1 safety and pharmacokinetics data for a recombinant Factor XIII product in patients with congenital Factor XIII deficiency are report…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725 [Phase 3]
Phase 3 extension study updates safety of monthly recombinant Factor XIII replacement in congenital Factor XIII deficiency.
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects [Phase 1]
Phase 1 study comparing recombinant factor XIII products produced by two manufacturers in healthy male volunteers to assess comparability.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency [Phase 3]
Phase 3 trial evaluating the safety and efficacy of monthly recombinant Factor XIII (rFXIII) in paediatric subjects with congenital Factor X…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency [Phase 3]
Phase 3 trial assessing the safety of a single intravenous dose of recombinant Factor XIII A-subunit in children with congenital Factor XIII…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating safety and pharmacokinetics of a recombinant Factor XIII in healthy volunteers has been completed.